Literature DB >> 33136280

The role of hepatobiliary scintigraphy combined with spect/ct in predicting severity of liver failure before major hepatectomy: a single-center pilot study.

Matteo Serenari1,2, Chiara Bonatti3, Lucia Zanoni4, Giuliano Peta5, Elena Tabacchi4, Alessandro Cucchetti3, Matteo Ravaioli6,3, Cinzia Pettinato7, Alberto Bagni8, Antonio Siniscalchi9, Antonietta D'Errico8, Rita Golfieri5, Stefano Fanti4, Matteo Cescon6,3.   

Abstract

Hepatobiliary scintigraphy (HBS) has been demonstrated to predict post-hepatectomy liver failure (PHLF). However, existing cutoff values for future liver remnant function (FLR-F) were previously set according to the "50-50 criteria" PHLF definition. Methods of calculation and fields of application in liver surgery have changed in the meantime. The aim of this study was to demonstrate the role of HBS combined with single photon emission computed tomography (SPECT/CT) in predicting severity of PHLF, according to the International Study Group of Liver Surgery (ISGLS). All patients submitted to major hepatectomy with preoperative HBS-SPECT/CT between November 2016 and December 2019, were analyzed. Patients were resected according to hepatic volumetry. Receiver operating characteristic (ROC) curve analysis was performed to identify cutoffs of FLR function for predicting PHLF according to ISGLS definition and grading. Of the 38 patients enrolled, 26 were submitted to one-stage hepatectomy (living liver donors = 4) and 12 to two-stage procedures (portal vein embolization = 4, ALPPS = 8). Overall, 18 patients developed PHLF according to ISGLS criteria: 12 of grade A (no change in the patient's clinical management) and 6 of grade B (change in clinical management). ROC analysis established increasingly higher cutoffs of FLR-F for predicting PHLF according to the "50-50 criteria", ISGLS grade B and ISGLS grade A/B, respectively. HBS with SPECT/CT may help to assess severity of PHLF following major hepatectomy. Prospective multicenter trials are needed to confirm the effective role of HBS-SPECT/CT in liver surgery.

Entities:  

Keywords:  Hepatectomy; Hepatobiliary scintigraphy; Liver failure; Mebrofenin; SPECT

Mesh:

Year:  2020        PMID: 33136280      PMCID: PMC7889556          DOI: 10.1007/s13304-020-00907-2

Source DB:  PubMed          Journal:  Updates Surg        ISSN: 2038-131X


  39 in total

1.  Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations.

Authors:  J N Vauthey; A Chaoui; K A Do; M M Bilimoria; M J Fenstermacher; C Charnsangavej; M Hicks; G Alsfasser; G Lauwers; I F Hawkins; J Caridi
Journal:  Surgery       Date:  2000-05       Impact factor: 3.982

2.  Increase in future remnant liver function after preoperative portal vein embolization.

Authors:  W de Graaf; K P van Lienden; J W van den Esschert; R J Bennink; T M van Gulik
Journal:  Br J Surg       Date:  2011-04-11       Impact factor: 6.939

3.  Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): what is gained and what is lost?

Authors:  Thomas A Aloia; Jean-Nicolas Vauthey
Journal:  Ann Surg       Date:  2012-09       Impact factor: 12.969

4.  Stress test of liver function using technetium-99m-mebrofenin hepatobiliary scintigraphy.

Authors:  Fadi Rassam; Kasia P Cieslak; Ulrich H W Beuers; Thomas M van Gulik; Roel J Bennink
Journal:  Nucl Med Commun       Date:  2019-04       Impact factor: 1.690

5.  Optimal use of hepatobiliary scintigraphy before liver resection.

Authors:  Pim B Olthof; Thomas M van Gulik; Roelof J Bennink
Journal:  HPB (Oxford)       Date:  2016-07-04       Impact factor: 3.647

6.  Future remnant liver function as predictive factor for the hypertrophy response after portal vein embolization.

Authors:  Kasia P Cieslak; Floor Huisman; Thomas Bais; Roelof J Bennink; Krijn P van Lienden; Joanne Verheij; Marc G Besselink; Olivier R C Busch; Thomas M van Gulik
Journal:  Surgery       Date:  2017-03-30       Impact factor: 3.982

7.  The Analysis of Posthepatectomy Liver Failure Incidence and Risk Factors Among Right Liver Living Donors According to International Study Group of Liver Surgery Definition.

Authors:  T Egeli; T Unek; C Agalar; M Ozbilgin; S Derici; A D Cevlik; M Akarsu; C Altay; F Obuz; H Ellidokuz; I Astarcioglu
Journal:  Transplant Proc       Date:  2019-02-07       Impact factor: 1.066

8.  Interstage Assessment of Remnant Liver Function in ALPPS Using Hepatobiliary Scintigraphy: Prediction of Posthepatectomy Liver Failure and Introduction of the HIBA Index.

Authors:  Matteo Serenari; Carlos Collaud; Fernando A Alvarez; Martin de Santibañes; Diego Giunta; Juan Pekolj; Victoria Ardiles; Eduardo de Santibañes
Journal:  Ann Surg       Date:  2018-06       Impact factor: 12.969

9.  Mebrofenin clearance rate for liver function testing: standardization of methodology aimed to improve intraobserver reproducibility.

Authors:  Mark Tulchinsky; Kyaw N Tun
Journal:  Clin Nucl Med       Date:  2012-07       Impact factor: 7.794

10.  (99m)Tc-mebrofenin hepatobiliary scintigraphy with SPECT for the assessment of hepatic function and liver functional volume before partial hepatectomy.

Authors:  Wilmar de Graaf; Krijn P van Lienden; Thomas M van Gulik; Roelof J Bennink
Journal:  J Nucl Med       Date:  2010-01-15       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.